There was no significant discrepancy of Aβ1-40, Aβ1-42, Aβ1-42/Aβ1-40, t-tau, or NfL among participants with different severity levels of AD (CDR = 1, 2, or 3). Here, MAPT is linked to Alzheimer disease.